Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof

Details for Australian Patent Application No. 2005230362 (hide)

International Classifications

Event Publications

16 November 2006 PCT application entered the National Phase

PCT publication WO2005/097194 Priority application(s): WO2005/097194

18 October 2007 Application Accepted

Published as AU-B-2005230362

14 February 2008 Standard Patent Sealed

27 January 2011 Assignment Registered

Hanmi Pharm. Co., Ltd. The patent has been assigned to Hanmi Holdings Co., Ltd.

30 August 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Hanmi Science Co., Ltd. . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.